Global LFA-based Cardiac Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global LFA-based Cardiac market size will reach 4,469.07 Million USD in 2025 and is projected to reach 7,092.27 Million USD by 2032, with a CAGR of 6.82% (2025-2032). Notably, the China LFA-based Cardiac market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
LFA-based cardiac detection refers to the use of lateral flow immunoassays (LFAs) in the diagnosis of cardiac conditions. LFAs are rapid, low-cost, and easy-to-use diagnostic tools based on immune reactions between antigens and antibodies. In cardiac diagnosis, LFAs can detect cardiac markers, such as troponin, myoglobin, and creatine kinase, in blood samples to confirm the presence of a heart attack or other cardiac diseases. LFA-based cardiac tests are widely used in emergency rooms, clinics, and hospitals for quick and reliable diagnosis of cardiac conditions.
The major global suppliers of LFA-based Cardiac include Thermo Fisher, Bio-Rad Laboratories, BD, Roche, Hologic, Abbott, Siemens, Danaher, Alere, BioMérieux, Clinical Diagnostics, LSI, Randox laboratories, Wondfo Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of LFA-based Cardiac. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global LFA-based Cardiac market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the LFA-based Cardiac market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of LFA-based Cardiac industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of LFA-based Cardiac Include:
Thermo Fisher
Bio-Rad Laboratories
BD
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioMérieux
Clinical Diagnostics
LSI
Randox laboratories
Wondfo Biotech
LFA-based Cardiac Product Segment Include:
Troponin I
Troponin T
CK-MB
Myoglobin
Others
LFA-based Cardiac Product Application Include:
Laboratory Testing
Point-of-care Testing
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global LFA-based Cardiac Industry PESTEL Analysis
Chapter 3: Global LFA-based Cardiac Industry Porter's Five Forces Analysis
Chapter 4: Global LFA-based Cardiac Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global LFA-based Cardiac Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global LFA-based Cardiac Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, LFA-based Cardiac Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global LFA-based Cardiac market size will reach 4,469.07 Million USD in 2025 and is projected to reach 7,092.27 Million USD by 2032, with a CAGR of 6.82% (2025-2032). Notably, the China LFA-based Cardiac market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
LFA-based cardiac detection refers to the use of lateral flow immunoassays (LFAs) in the diagnosis of cardiac conditions. LFAs are rapid, low-cost, and easy-to-use diagnostic tools based on immune reactions between antigens and antibodies. In cardiac diagnosis, LFAs can detect cardiac markers, such as troponin, myoglobin, and creatine kinase, in blood samples to confirm the presence of a heart attack or other cardiac diseases. LFA-based cardiac tests are widely used in emergency rooms, clinics, and hospitals for quick and reliable diagnosis of cardiac conditions.
The major global suppliers of LFA-based Cardiac include Thermo Fisher, Bio-Rad Laboratories, BD, Roche, Hologic, Abbott, Siemens, Danaher, Alere, BioMérieux, Clinical Diagnostics, LSI, Randox laboratories, Wondfo Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of LFA-based Cardiac. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global LFA-based Cardiac market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the LFA-based Cardiac market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of LFA-based Cardiac industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of LFA-based Cardiac Include:
Thermo Fisher
Bio-Rad Laboratories
BD
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioMérieux
Clinical Diagnostics
LSI
Randox laboratories
Wondfo Biotech
LFA-based Cardiac Product Segment Include:
Troponin I
Troponin T
CK-MB
Myoglobin
Others
LFA-based Cardiac Product Application Include:
Laboratory Testing
Point-of-care Testing
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global LFA-based Cardiac Industry PESTEL Analysis
Chapter 3: Global LFA-based Cardiac Industry Porter's Five Forces Analysis
Chapter 4: Global LFA-based Cardiac Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global LFA-based Cardiac Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global LFA-based Cardiac Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, LFA-based Cardiac Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 LFA-based Cardiac Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 LFA-based Cardiac Product by Type
- 1.2.1 Troponin I
- 1.2.2 Troponin T
- 1.2.3 CK-MB
- 1.2.4 Myoglobin
- 1.2.5 Others
- 1.3 LFA-based Cardiac Product by Application
- 1.3.1 Laboratory Testing
- 1.3.2 Point-of-care Testing
- 1.4 Global LFA-based Cardiac Market Size Analysis (2020-2032)
- 1.5 LFA-based Cardiac Market Development Status and Trends
- 1.5.1 LFA-based Cardiac Industry Development Status Analysis
- 1.5.2 LFA-based Cardiac Industry Development Trends Analysis
- 2 LFA-based Cardiac Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 LFA-based Cardiac Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global LFA-based Cardiac Market Analysis by Country
- 4.1 Global LFA-based Cardiac Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global LFA-based Cardiac Revenue Analysis by Country (2020-2025)
- 4.1.2 Global LFA-based Cardiac Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.5 China LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.6 France LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.14 India LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa LFA-based Cardiac Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global LFA-based Cardiac Market Revenue by Key Suppliers (2021-2025)
- 5.2 LFA-based Cardiac Competitive Landscape Analysis and Market Dynamic
- 5.2.1 LFA-based Cardiac Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 LFA-based Cardiac Market Analysis by Type
- 6.1 Global LFA-based Cardiac Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global LFA-based Cardiac Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Thermo Fisher
- 7.1.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Thermo Fisher LFA-based Cardiac Product Portfolio
- 7.1.3 Thermo Fisher LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Bio-Rad Laboratories
- 7.2.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Bio-Rad Laboratories LFA-based Cardiac Product Portfolio
- 7.2.3 Bio-Rad Laboratories LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 BD
- 7.3.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 BD LFA-based Cardiac Product Portfolio
- 7.3.3 BD LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Roche
- 7.4.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Roche LFA-based Cardiac Product Portfolio
- 7.4.3 Roche LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Hologic
- 7.5.1 Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Hologic LFA-based Cardiac Product Portfolio
- 7.5.3 Hologic LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Abbott
- 7.6.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Abbott LFA-based Cardiac Product Portfolio
- 7.6.3 Abbott LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Siemens
- 7.7.1 Siemens Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Siemens LFA-based Cardiac Product Portfolio
- 7.7.3 Siemens LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Danaher
- 7.8.1 Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Danaher LFA-based Cardiac Product Portfolio
- 7.8.3 Danaher LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Alere
- 7.9.1 Alere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Alere LFA-based Cardiac Product Portfolio
- 7.9.3 Alere LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 BioMérieux
- 7.10.1 BioMérieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 BioMérieux LFA-based Cardiac Product Portfolio
- 7.10.3 BioMérieux LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Clinical Diagnostics
- 7.11.1 Clinical Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Clinical Diagnostics LFA-based Cardiac Product Portfolio
- 7.11.3 Clinical Diagnostics LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 LSI
- 7.12.1 LSI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 LSI LFA-based Cardiac Product Portfolio
- 7.12.3 LSI LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Randox laboratories
- 7.13.1 Randox laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Randox laboratories LFA-based Cardiac Product Portfolio
- 7.13.3 Randox laboratories LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Wondfo Biotech
- 7.14.1 Wondfo Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Wondfo Biotech LFA-based Cardiac Product Portfolio
- 7.14.3 Wondfo Biotech LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 LFA-based Cardiac Industry Chain Analysis
- 8.2 LFA-based Cardiac Product Downstream Application Analysis
- 8.2.1 Global LFA-based Cardiac Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global LFA-based Cardiac Revenue and Forecast by Application (2020-2032)
- 8.3 LFA-based Cardiac Typical Downstream Customers
- 8.4 LFA-based Cardiac Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
